Yes it is interesting !
Referring to the DeGrey ENDING AGING book he discusses strategies to fight cancer. One strategy is to turn off (block) telomerase in cancer cells because the more aggressive the cancer cell, the more telomerase they have to generate to support cell division.
Cancer cells have "learned" how to overcome the blocking protein that normally keeps telomerase shut off in human cells. Apparently they know how to do keep the blocking protein blocking, are able to turn off telomerase in cancer cells in test tubes, and cancer cells quickly die out.
So they tried a very interesting laboratory experiment in animals injecting them with a virus designed to block telomerase.
When the virus was not targeted - the animals lived longer, but one result was severe liver failure (When they were able to target the virus only to cancer cells, it was as or more successful - without the liver failure.)
Ergo, turning off telomerase harms the liver.
This experiment seems to show that the liver requires telomerase - perhaps more than other cells capable of cell division, and Bill Andrews mentioned that all cells have some telomerase, usually very little.
Putting this together, given silymarin's has remarkable restorative effects on the liver, and now silmyarin's strong property promoting telomerase, we not only have an explanation why silymarin may be so effective for liver malfunctions, but a strong indicator that in any telomerase activation strategy - silymarin is probably an important adjunct.
Owen R. Fonorow, Orthopath® (Orthomolecular Naturopath)
® is a trademark of the Institute for Orthomolecular Studies